Edition:
United Kingdom

Vital Therapies Inc (VTL.OQ)

VTL.OQ on NASDAQ Stock Exchange Global Select Market

5.55USD
15 Dec 2017
Change (% chg)

$0.05 (+0.91%)
Prev Close
$5.50
Open
$5.60
Day's High
$5.75
Day's Low
$5.40
Volume
702,946
Avg. Vol
31,006
52-wk High
$6.50
52-wk Low
$2.25

Chart for

About

Vital Therapies, Inc. is a biotherapeutic company. The Company is focused on developing a human hepatic cell-based treatment targeting acute forms of liver failure. Its product candidate, the ELAD System, is an extracorporeal human allogeneic cellular liver therapy designed to allow the patient's liver to regenerate to a healthy... (more)

Overall

Beta: 5.35
Market Cap(Mil.): $249.02
Shares Outstanding(Mil.): 42.21
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 88.66 16.44
EPS (TTM): -- -- --
ROI: -- 2.36 10.62
ROE: -- 2.96 14.20

BRIEF-Vital Therapies Appoints Russell J. Cox As Chief Executive Officer And Board Member

* VITAL THERAPIES APPOINTS RUSSELL J. COX AS CHIEF EXECUTIVE OFFICER AND BOARD MEMBER EFFECTIVE JANUARY 3, 2018

04 Dec 2017

BRIEF-Vital Therapies reports Q3 loss per share $0.30

* Vital therapies announces third quarter 2017 financial results

25 Oct 2017

BRIEF-Vital Therapies Q2 loss per share $0.29

* Vital Therapies announces second quarter 2017 financial results

03 Aug 2017

Earnings vs. Estimates